ACADIA Pharmaceuticals Inc.
ACADIA, a San Diego‑based biopharma, develops CNS drugs. Portfolio includes NUPLAZID® for Parkinson’s psychosis, DAYBUE® for Rett, and Phase III candidates for Alzheimer’s and schizophrenia psychosis. Agreements with Neuren and Stoke Therapeutics broaden its RNA‑based platform.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- Employees: 653
- HQ: San Diego
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.